N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats
Doxorubicin (DOX) is an anthracyclin antibiotic used for the treatment of various cancers. Nephrotoxicity is among the serious side effects of DOX, therefore, DOX-induced nephrotoxic model has been widely used to study nephropathies. The objectives of this study is to investigate the possible anti-i...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2023-10, Vol.123, p.110741-110741, Article 110741 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 110741 |
---|---|
container_issue | |
container_start_page | 110741 |
container_title | International immunopharmacology |
container_volume | 123 |
creator | Shams, Sidrah Lubbad, Loay Ibrahim Simjee, Shabana U Jabeen, Almas |
description | Doxorubicin (DOX) is an anthracyclin antibiotic used for the treatment of various cancers. Nephrotoxicity is among the serious side effects of DOX, therefore, DOX-induced nephrotoxic model has been widely used to study nephropathies. The objectives of this study is to investigate the possible anti-inflammatory and nephroprotective effects of salicylic acid derivative, N-(2-hydroxy phenyl) acetamide (NA-2), in a rat model of DOX-induced nephrotoxicity. The in vitro anti-inflammatory potential of NA-2 was manifested by whole blood oxidative burst and nitric oxide (NO) assays with no toxicity on normal human fibroblast (BJ) cells, human embryonic kidney (HEK-293) cells, and normal monkey kidney epithelial (Vero) cells. The in vivo study included five groups: Normal control, DOX (6 mg/kg DOX-i.v.via tail vein), NA-2 treated control-i.p., NA-2/DOX treated-i.p., and prednisolone/DOX treated. After 7 days of DOX administration, rats with urinary protein level of >50 mg/kg/day were selected. Treatment group rats received i.p. doses of NA-2 (10 mg/kg/day) for 3 weeks with weekly monitoring of urinary protein excretion and body weights. mRNA expression of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, and kidney injury molecule (KIM)-1 was analyzed by quantitative polymerase chain reaction (qPCR). Protein expressions were analyzed by immunohistochemistry. NA-2 attenuated DOX-induced changes in serum and urine levels, and improved inflammatory profile of the renal tissue. Histopathological findings revealed protective effects of NA-2 showing lesser lesions. We conclude that NA-2 is able to protect against DOX-induced renal damage functionally, biochemically and histopathologically with corresponding improvement in the kidney inflammatory profile. |
doi_str_mv | 10.1016/j.intimp.2023.110741 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2850312133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2850312133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-39e8f86159a4c0f2355c4a88816919f806410ae08f39b1c8813e5e9b21793d953</originalsourceid><addsrcrecordid>eNo9kE1LxDAQhoMorl__QKTH9dA1kzRtchTxCxa96Dlk0ymbpU1q0sL231tZ9TTDy_vMwEPINdAVUCjvdivnB9f1K0YZXwHQqoAjcgaykjlUVBzPuyirXFSlWpDzlHaUznkBp2TBK1ExQYszgm_5kuXbqY5hP2X9Fv3U3mbG4mA6V2NmOmxdiGbAzPmmNV1nBhd8Znyd1WEf4rhx1vnc-Xq0WGce-20MQ9jP6TDNTDaz6ZKcNKZNePU7L8jn0-PHw0u-fn9-fbhf55aJcsi5QtnIEoQyhaUN40LYwkgpoVSgGknLAqhBKhuuNmDnnKNAtWFQKV4rwS_I8nC3j-FrxDToziWLbWs8hjFpJgXlwIDzuVocqjaGlCI2uo-uM3HSQPWPYL3TB8H6R7A-CJ6xm98P46bD-h_6M8q_AXmAeRc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2850312133</pqid></control><display><type>article</type><title>N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats</title><source>Access via ScienceDirect (Elsevier)</source><creator>Shams, Sidrah ; Lubbad, Loay Ibrahim ; Simjee, Shabana U ; Jabeen, Almas</creator><creatorcontrib>Shams, Sidrah ; Lubbad, Loay Ibrahim ; Simjee, Shabana U ; Jabeen, Almas</creatorcontrib><description>Doxorubicin (DOX) is an anthracyclin antibiotic used for the treatment of various cancers. Nephrotoxicity is among the serious side effects of DOX, therefore, DOX-induced nephrotoxic model has been widely used to study nephropathies. The objectives of this study is to investigate the possible anti-inflammatory and nephroprotective effects of salicylic acid derivative, N-(2-hydroxy phenyl) acetamide (NA-2), in a rat model of DOX-induced nephrotoxicity. The in vitro anti-inflammatory potential of NA-2 was manifested by whole blood oxidative burst and nitric oxide (NO) assays with no toxicity on normal human fibroblast (BJ) cells, human embryonic kidney (HEK-293) cells, and normal monkey kidney epithelial (Vero) cells. The in vivo study included five groups: Normal control, DOX (6 mg/kg DOX-i.v.via tail vein), NA-2 treated control-i.p., NA-2/DOX treated-i.p., and prednisolone/DOX treated. After 7 days of DOX administration, rats with urinary protein level of >50 mg/kg/day were selected. Treatment group rats received i.p. doses of NA-2 (10 mg/kg/day) for 3 weeks with weekly monitoring of urinary protein excretion and body weights. mRNA expression of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, and kidney injury molecule (KIM)-1 was analyzed by quantitative polymerase chain reaction (qPCR). Protein expressions were analyzed by immunohistochemistry. NA-2 attenuated DOX-induced changes in serum and urine levels, and improved inflammatory profile of the renal tissue. Histopathological findings revealed protective effects of NA-2 showing lesser lesions. We conclude that NA-2 is able to protect against DOX-induced renal damage functionally, biochemically and histopathologically with corresponding improvement in the kidney inflammatory profile.</description><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2023.110741</identifier><identifier>PMID: 37572504</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>International immunopharmacology, 2023-10, Vol.123, p.110741-110741, Article 110741</ispartof><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-39e8f86159a4c0f2355c4a88816919f806410ae08f39b1c8813e5e9b21793d953</cites><orcidid>0000-0002-6043-9539</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37572504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shams, Sidrah</creatorcontrib><creatorcontrib>Lubbad, Loay Ibrahim</creatorcontrib><creatorcontrib>Simjee, Shabana U</creatorcontrib><creatorcontrib>Jabeen, Almas</creatorcontrib><title>N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>Doxorubicin (DOX) is an anthracyclin antibiotic used for the treatment of various cancers. Nephrotoxicity is among the serious side effects of DOX, therefore, DOX-induced nephrotoxic model has been widely used to study nephropathies. The objectives of this study is to investigate the possible anti-inflammatory and nephroprotective effects of salicylic acid derivative, N-(2-hydroxy phenyl) acetamide (NA-2), in a rat model of DOX-induced nephrotoxicity. The in vitro anti-inflammatory potential of NA-2 was manifested by whole blood oxidative burst and nitric oxide (NO) assays with no toxicity on normal human fibroblast (BJ) cells, human embryonic kidney (HEK-293) cells, and normal monkey kidney epithelial (Vero) cells. The in vivo study included five groups: Normal control, DOX (6 mg/kg DOX-i.v.via tail vein), NA-2 treated control-i.p., NA-2/DOX treated-i.p., and prednisolone/DOX treated. After 7 days of DOX administration, rats with urinary protein level of >50 mg/kg/day were selected. Treatment group rats received i.p. doses of NA-2 (10 mg/kg/day) for 3 weeks with weekly monitoring of urinary protein excretion and body weights. mRNA expression of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, and kidney injury molecule (KIM)-1 was analyzed by quantitative polymerase chain reaction (qPCR). Protein expressions were analyzed by immunohistochemistry. NA-2 attenuated DOX-induced changes in serum and urine levels, and improved inflammatory profile of the renal tissue. Histopathological findings revealed protective effects of NA-2 showing lesser lesions. We conclude that NA-2 is able to protect against DOX-induced renal damage functionally, biochemically and histopathologically with corresponding improvement in the kidney inflammatory profile.</description><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kE1LxDAQhoMorl__QKTH9dA1kzRtchTxCxa96Dlk0ymbpU1q0sL231tZ9TTDy_vMwEPINdAVUCjvdivnB9f1K0YZXwHQqoAjcgaykjlUVBzPuyirXFSlWpDzlHaUznkBp2TBK1ExQYszgm_5kuXbqY5hP2X9Fv3U3mbG4mA6V2NmOmxdiGbAzPmmNV1nBhd8Znyd1WEf4rhx1vnc-Xq0WGce-20MQ9jP6TDNTDaz6ZKcNKZNePU7L8jn0-PHw0u-fn9-fbhf55aJcsi5QtnIEoQyhaUN40LYwkgpoVSgGknLAqhBKhuuNmDnnKNAtWFQKV4rwS_I8nC3j-FrxDToziWLbWs8hjFpJgXlwIDzuVocqjaGlCI2uo-uM3HSQPWPYL3TB8H6R7A-CJ6xm98P46bD-h_6M8q_AXmAeRc</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Shams, Sidrah</creator><creator>Lubbad, Loay Ibrahim</creator><creator>Simjee, Shabana U</creator><creator>Jabeen, Almas</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6043-9539</orcidid></search><sort><creationdate>20231001</creationdate><title>N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats</title><author>Shams, Sidrah ; Lubbad, Loay Ibrahim ; Simjee, Shabana U ; Jabeen, Almas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-39e8f86159a4c0f2355c4a88816919f806410ae08f39b1c8813e5e9b21793d953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shams, Sidrah</creatorcontrib><creatorcontrib>Lubbad, Loay Ibrahim</creatorcontrib><creatorcontrib>Simjee, Shabana U</creatorcontrib><creatorcontrib>Jabeen, Almas</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shams, Sidrah</au><au>Lubbad, Loay Ibrahim</au><au>Simjee, Shabana U</au><au>Jabeen, Almas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>123</volume><spage>110741</spage><epage>110741</epage><pages>110741-110741</pages><artnum>110741</artnum><issn>1567-5769</issn><eissn>1878-1705</eissn><abstract>Doxorubicin (DOX) is an anthracyclin antibiotic used for the treatment of various cancers. Nephrotoxicity is among the serious side effects of DOX, therefore, DOX-induced nephrotoxic model has been widely used to study nephropathies. The objectives of this study is to investigate the possible anti-inflammatory and nephroprotective effects of salicylic acid derivative, N-(2-hydroxy phenyl) acetamide (NA-2), in a rat model of DOX-induced nephrotoxicity. The in vitro anti-inflammatory potential of NA-2 was manifested by whole blood oxidative burst and nitric oxide (NO) assays with no toxicity on normal human fibroblast (BJ) cells, human embryonic kidney (HEK-293) cells, and normal monkey kidney epithelial (Vero) cells. The in vivo study included five groups: Normal control, DOX (6 mg/kg DOX-i.v.via tail vein), NA-2 treated control-i.p., NA-2/DOX treated-i.p., and prednisolone/DOX treated. After 7 days of DOX administration, rats with urinary protein level of >50 mg/kg/day were selected. Treatment group rats received i.p. doses of NA-2 (10 mg/kg/day) for 3 weeks with weekly monitoring of urinary protein excretion and body weights. mRNA expression of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, and kidney injury molecule (KIM)-1 was analyzed by quantitative polymerase chain reaction (qPCR). Protein expressions were analyzed by immunohistochemistry. NA-2 attenuated DOX-induced changes in serum and urine levels, and improved inflammatory profile of the renal tissue. Histopathological findings revealed protective effects of NA-2 showing lesser lesions. We conclude that NA-2 is able to protect against DOX-induced renal damage functionally, biochemically and histopathologically with corresponding improvement in the kidney inflammatory profile.</abstract><cop>Netherlands</cop><pmid>37572504</pmid><doi>10.1016/j.intimp.2023.110741</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-6043-9539</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1567-5769 |
ispartof | International immunopharmacology, 2023-10, Vol.123, p.110741-110741, Article 110741 |
issn | 1567-5769 1878-1705 |
language | eng |
recordid | cdi_proquest_miscellaneous_2850312133 |
source | Access via ScienceDirect (Elsevier) |
title | N-(2-hydroxy phenyl) acetamide ameliorate inflammation and doxorubicin-induced nephrotoxicity in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A01%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-(2-hydroxy%20phenyl)%20acetamide%20ameliorate%20inflammation%20and%20doxorubicin-induced%20nephrotoxicity%20in%20rats&rft.jtitle=International%20immunopharmacology&rft.au=Shams,%20Sidrah&rft.date=2023-10-01&rft.volume=123&rft.spage=110741&rft.epage=110741&rft.pages=110741-110741&rft.artnum=110741&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2023.110741&rft_dat=%3Cproquest_cross%3E2850312133%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2850312133&rft_id=info:pmid/37572504&rfr_iscdi=true |